<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: Mutations in the lamin A/C gene (LMNA) cause a variety of clinical phenotypes, including <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>LMNA is one of the most prevalent mutated genes in <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo>, and is associated with a high risk of <z:hpo ids='HP_0011675'>arrhythmias</z:hpo>, <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo>, and <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>There are few data on the impact of age and gender on <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac disease</z:e> penetrance and mortality </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS AND RESULTS: In a multicentre cohort of 269 LMNA mutation carriers, we evaluated gender-specific penetrance of cardiac involvement and major cardiac events </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo>-cause mortality of mutation carriers [standardized mortality ratio (SMR)] was determined </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">Cardiac disease</z:e> penetrance was age dependent and almost complete at the age of 70 years </plain></SENT>
<SENT sid="6" pm="."><plain>The presence of an LVEF â‰¤45% was significantly higher in men (P &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>However, there was no difference between genders in the prevalence of <z:hpo ids='HP_0001678'>atrioventricular block</z:hpo>, atrial tachyarrhythmias, and non-sustained <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Malignant <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> (26% vs. 8%) and end-stage <z:hpo ids='HP_0001635'>heart failure</z:hpo> (28% vs. 14%) were more common in men than in women (P &lt; 0.001 and P = 0.006, respectively) </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo>-cause mortality of mutation carriers was significantly increased [SMR 4.0, 95% confidence interval (CI) 2.8-5.2] between the ages of 15 and 75 years </plain></SENT>
<SENT sid="10" pm="."><plain>Mortality in men was higher than in women (hazard ratio 2.2, 95% CI 1.2-4.3) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: This large cohort of LMNA mutation carriers demonstrates a high <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac disease</z:e> penetrance and a high mortality in mutation carriers </plain></SENT>
<SENT sid="12" pm="."><plain>Male mutation carriers have a worse prognosis due to a higher prevalence of malignant <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> and end-stage <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
</text></document>